Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · September 14, 2023

Effectiveness of Intralesional Measles, Mumps, and Rubella Vaccine After Failure of Intralesional Candida Antigen in Pediatric Patients With Recalcitrant Warts

Pediatric Dermatology


Additional Info

Pediatric Dermatology
Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts
Pediatr Dermatol 2023 Aug 19;[EPub Ahead of Print], CM Ulschmid, J Patel, AY Pan, M Liegl, KE Holland

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading